Working… Menu

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00492843
Recruitment Status : Terminated (It is too difficult to recruit suitable patients.)
First Posted : June 27, 2007
Last Update Posted : February 17, 2016
Information provided by (Responsible Party):
Yi-Long Wu, Chinese Society of Lung Cancer

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 2008
Actual Study Completion Date : July 2008